| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5833524 | International Immunopharmacology | 2012 | 9 Pages |
Abstract
⺠Anakinra is an interleukin-1 (IL-1) receptor antagonist. ⺠Positive and negative effects of anakinra in treatment of inflammatory disorders. ⺠The interactions among IL-1rn and its partner are complex. ⺠Different splicing, background, and environment affect its therapeutic application.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Yanhong Cao, Yan Jiao, Lishi Wang, Yue Huang, Arnold Postlethwaite, John Stuart, Andy Kang, Robert W. Williams, Weikuan Gu,